Clinical Trials Logo

Clinical Trial Summary

This is a prospective study to assess efficacy of the Nevisense device in identifying keratinocyte skin cancer (KC) in patients suspected of having skin cancer based on the initial physician's assessment. All skin lesions with a suspicion of Basal cell carcinoma (BCC), Invasive Squamos cell Carcinoma (iSCC), Bowen's disease (BD) or actinic keratosis (AK) and destined for excision or biopsy for further histopathological analysis will be considered for inclusion in the study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06064019
Study type Interventional
Source SciBase AB
Contact Per Svedenhag
Phone +46 8410 620 01
Email per.svedenhag@scibase.com
Status Recruiting
Phase N/A
Start date July 13, 2023
Completion date September 2024

See also
  Status Clinical Trial Phase
Completed NCT03607578 - Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations N/A